Biotechnology News

August 14, 2014

VALENCIA, Calif.--(BUSINESS WIRE)--Advanced Bionics, a global leader in cochlear implant technology, announced the launch of two apps designed to guide the development of listening and language skills in children with hearing loss.

August 14, 2014

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Two leading health care technology companies have announced they will collaborate to develop integrated solutions for providers in an increasingly interconnected health care environment. Netsmart and...

August 14, 2014

DAVIS, Calif.--(BUSINESS WIRE)--BioConsortia names Christina Huben & Susan Turner, PhD, Senior Vice Presidents for Operations and R & D

August 14, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN), a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, is providing an overview of its three clinical...

August 14, 2014

DURHAM, N.C.--(BUSINESS WIRE)--Novan Therapeutics to present antiviral data from a preclinical study at the 2014 Interscience Conference on Antimicrobial Agents and Chemotherapy - Presentation Number V-1822a

August 14, 2014

CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group (NYSE MKT: XXII) Reports Second Quarter 2014 Financial Results. The Company’s net loss for the three months ended June 30, 2014 was $1.97 million or ($0.03) per share.

August 14, 2014

KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the first quarter of fiscal year 2015,...

August 14, 2014

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces the signing of a commercial license agreement with Avion Pharmaceuticals, LLC for the development and commercialization of four Captisol-enabled programs....

August 14, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nodality, Inc., an innovative biotechnology company advancing discovery, development and use of transformative therapies across broad therapeutic categories, with a focus on immunology and oncology,...

August 14, 2014

WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--BASi 3Q rev. $6,032,000 vs $5,600,000, net inc. $215,000 ($0.02/sh) vs $576,000 ($0.07/sh). 9 mo. rev $18,164,000 vs $16,560,000, loss $666,000 ($0.08/sh) vs inc. $521,000 ($0.06/sh).

August 14, 2014

SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company Receives Notice of Allowance for Additional Patent Claims Covering Modified Pectin for the Treatment of Chronic Inflammation

August 14, 2014

NEW HAVEN, Conn.--(BUSINESS WIRE)--Trevi Therapeutics issued two patents
covering the oral sustained release formulation of Nalbuphine ER.

August 14, 2014

NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces financial results for the three and six months ended June 30, 2014. Financial...

August 14, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--SAGE Therapeutics reports second quarter 2014 financial results. Successfully completed initial public offering and reported preliminary results for SAGE-547 in super-refractory status epilepticus.

August 13, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today provided the following statement regarding the U.S. Centers for Disease Control and Prevention’s Advisory Committee.

August 13, 2014

NASHVILLE, Tenn.--(BUSINESS WIRE)--Venture Forum to be held in Nashville, Tenn., Oct. 20-22.

August 13, 2014

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion announced that new data from studies of asfotase alfa in pediatric patients with hypophosphatasia will be presented at the American Society for Bone and Mineral Research 2014 Annual Meeting.

August 13, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) today issued financial and operational results for its fiscal second quarter ended June 30, 2014. “The utilization of our PerioPredict™ genetic test in the dental office is...

August 13, 2014

WASHINGTON--(BUSINESS WIRE)--The majority of Americans report they have had a good year when it comes to their personal health and are paying more attention to their health compared to just a few years ago, according to From Hope to Cures: PhRMA’...

August 13, 2014

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal launches four new generics - acyclovir ointment, atovaquone oral suspension, clindamycin palmitate HCl for oral solution, and oxycodone HCl tablets – with $900M annual U.S. market value.

August 13, 2014

CINCINNATI--(BUSINESS WIRE)--Rare disease specialty pharmacy, BioRx, demonstrates quality standards with URAC accreditation.

August 13, 2014

DUBLIN, Ireland--(BUSINESS WIRE)--Covidien: FORM 8.1(a)&(b)(i) IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN...

August 13, 2014

ST. LOUIS & SAN DIEGO--(BUSINESS WIRE)--Otonomy, a RiverVest Fund II portfolio company that develops drug therapies for the inner and middle ear, announced today its $100 million initial public offering.

August 13, 2014

BOSTON & GENEVA--(BUSINESS WIRE)--PHT Corporation VP of Clinical Science and Consulting Services Dr. Susan Dallabrida is named to the 2014 PharmaVOICE 100 for innovating technologies that collect patient-driven data.

August 13, 2014

EXTON, Pa.--(BUSINESS WIRE)--DSM, a global leader in materials science and regenerative medicine, announced today the launch of its cellular therapy development services. Cellular therapies use a patient’s own cells to improve healing of an...

August 13, 2014

DORTMUND, Germany--(BUSINESS WIRE)--Protagen AG, a developer of powerful diagnostic tools to address autoimmune diseases, has today launched its first ELISA research use test kit for Systemic Sclerosis (SSc), the ADx®SSc Multilisa®.

August 13, 2014

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Comprehend's VP and Clinical Analytics Evangelist Ben McGraw to present at eSource Data in Clinical Investigations Conference on generating actionable analytics for sponsors and CROs.

August 13, 2014

SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (the “Company” or “BSD”) announced today that on August 8, 2014, it received a letter from the NASDAQ OMX GROUP (“Nasdaq”) stating that the bid price of the Company’s common...

August 13, 2014

SAN DIEGO--(BUSINESS WIRE)--Publication of a review article entitled “Identifying and Overcoming Obstacles in Angiogenic Gene Therapy for Myocardial Ischemia,” in the August 2014 issue of Journal of Cardiovascular Pharmacology

August 13, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on ophthalmology, today announced that David. P. Southwell has been named President and Chief Executive Officer. Mr. Southwell...

August 13, 2014

FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. will participate in the Morgan Stanley Global Healthcare Conference on Wednesday, Sept. 10, in New York City.

August 13, 2014

LOS ANGELES--(BUSINESS WIRE)--The Board of Directors of RightSmile, Inc. passed a resolution yesterday to change the company’s name to Bud Genius, Inc. A new ticker symbol will be assigned after the name change.

August 13, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Liquidia Technologies today announced that it will present new data demonstrating the influence of tunable PRINT® (Particle Replication In Non-Wetting Templates) particle characteristics on the...

August 13, 2014

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, is proud to announce the first implantation of the Alteon™...

August 13, 2014

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced the August 12, 2014 pricing of $225 million aggregate principal amount of 0.75% convertible senior notes due 2019 in a private offering to qualified...

August 13, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced second quarter 2014 operating...

August 13, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eleven Biotherapeutics, Inc. (Nasdaq: EBIO) today reported business highlights and financial results for the second quarter ended June 30, 2014,

August 13, 2014

BURR RIDGE, Ill.--(BUSINESS WIRE)--Project management consulting firm IPM opens new regional office in Minneapolis/St. Paul, expanding its reach to the Twin Cities.

August 13, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seventh Sense Biosystems Closes $16 Million Series B Financing. Siemens, Novartis and LabCorp® Join Polaris Partners and Flagship Ventures to Fund Development of Patented Blood Collection System

August 13, 2014

PORTLAND, Ore.--(BUSINESS WIRE)--Sedia Biosciences announces its newest product, the Asanté™ DNA Specimen Collection Kit, a new cost-effective method for collecting DNA specimens from oral and other biological fluids and tissues.

August 13, 2014

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences Inc., a cancer-focused molecular diagnostics company, today announced the completion of an $11.8 million financing. The round was led by new investor HealthQuest Capital, with participation...

August 13, 2014

SEATTLE--(BUSINESS WIRE)--Blaze Bioscience Announces Presentation at the 2014 Wedbush PacGrow Life Sciences Management Access Conference in New York on August 13, 2014

August 12, 2014

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Insmed Incorporated (Nasdaq: INSM) announced today that it priced an offering of 8.9 million shares of its common stock at a price of $11.25 per share in a registered underwritten public offering for gross...

August 12, 2014

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides will ring The Opening Bell(r) at NYSE tomorrow, August 13, 2014.

August 12, 2014

INDIANAPOLIS--(BUSINESS WIRE)--Indy Composite Works (ICW), composite manufacturer, and the IU Health Proton Therapy Center joined to manufacture a customized patient treatment table improving the precision of proton therapy.

August 12, 2014

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today top-line results from two placebo-controlled studies conducted in China with Lyrica® (pregabalin) in patients with postherpetic neuralgia (pain after shingles or PHN) and painful...